Cargando…
Doxorubicin-loading core-shell pectin nanocell: A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal
Tumor is a prevalent great threat to public health worldwide and multidrug resistance (MDR) of tumor is a leading cause of chemotherapy failure. Nanomedicine has shown prospects in overcoming the problem. Doxorubicin (DOX), a broad-spectrum anticancer drug, showed limited efficacy due to MDR. Herein...
Autores principales: | Ouyang, Jiabi, Yang, Mohui, Gong, Tian, Ou, Jinlai, Tan, Yani, Zhang, Zhen, Li, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307773/ https://www.ncbi.nlm.nih.gov/pubmed/32569270 http://dx.doi.org/10.1371/journal.pone.0235090 |
Ejemplares similares
-
Nanocell targeting using engineered bispecific antibodies
por: Taylor, Karin, et al.
Publicado: (2014) -
Self-assembly of Deinococcus radiodurans supports nanocell scenario of life origin
por: Bernadotte, Alexandra, et al.
Publicado: (2017) -
Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021) -
In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery
por: Meaney, Cameron, et al.
Publicado: (2020) -
Self-Assembling pH-Responsive Nanoparticle Platform
Based on Pectin–Doxorubicin Conjugates for Codelivery of Anticancer
Drugs
por: Tao, Yinghua, et al.
Publicado: (2021)